Target intelligence / Profile preview

Potassium inward rectifier channel subfamily J member 2 (Kir2.2)

Target
Kir2.2
Molecular classification
Ion channel, Potassium channel, Inward rectifier potassium channel
01

Overview

The potassium inward rectifier channel subfamily J member 2 (Kir2.2, encoded by KCNJ2) is a tetrameric ion channel that allows K(+) ions to move more readily into cells than out, playing a critical role in maintaining the resting membrane potential of many cell types, especially cardiac and skeletal muscle cells[2][3][4][6]. Kir2.2 channels stabilize the membrane potential and are important for terminal repolarization during the cardiac action potential[4]. Channel opening is strongly dependent on binding of phosphatidylinositol 4,5-bisphosphate (PIP_2) at the interface between its transmembrane and cytoplasmic domains, which induces conformational changes to permit K(+) conduction[3][4][6]. Dysfunction or mutation of Kir2.2 (KCNJ2) is associated with inherited arrhythmia syndromes such as Andersen-Tawil syndrome and is also implicated in skeletal and smooth muscle excitability disorders[4]. Several drugs—including some antiarrhythmics—can interact with inward rectifier potassium channels and alter their function, which can pose risks of arrhythmia or be of therapeutic benefit in controlling abnormal heart rhythms[4]. The Kir2.2 channel is crucial for membrane stability, excitability, and the regulation of action potentials in excitable tissues[2][4].

Other names
KCNJ2Kir2.2Inward rectifier potassium channel 2IRK-2
02

Mechanism of action

Channel blockade (by antiarrhythmics, pharmacological inhibitors), Modulation of channel activity (via phospholipids such as PIP_2)

03

Biological functions

Maintenance of resting membrane potentialCardiac action potential repolarizationRegulation of cell excitability
04

Disease associations

Cardiovascular disease (e.g., arrhythmias such as Andersen-Tawil syndrome, atrial fibrillation)Neuromuscular disordersOther channelopathies
05

Safety considerations

Risk of cardiac arrhythmias (QT prolongation, ventricular tachycardia)Potential for neuromuscular symptoms (associated with channelopathies)
06

Interacting drugs

Amiodarone

4 more in the full profile.

07

Biomarkers

Mutations in KCNJ2 for Andersen-Tawil syndromeCardiac repolarization profiles (ECG QT interval)

Beyond the preview

Go deeper on Potassium inward rectifier channel subfamily J member 2 (Kir2.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium inward rectifier channel subfamily J member 2 (Kir2.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call